Immunovia Announces Positive Results from the IMMray™ PanCan-d Verification Study |
September 29, 2020 | September 2020 Bond Updates |
LUND, Sweden, Sept. 29, 2020 /PRNewswire/ -- Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced positive results from the verification study and will now commence the validation study, the... |
View more at: https://www.prnewswire.com:443/news-releases/immunovia-announces-positive-results-from-the-immray-pancan-d-verification-study-301139551.html |
Related News |
|